evaluating

Related by string. evaluated * * rigorously evaluated . Study Evaluating . evaluating ispinesib . evaluating OGX . Evaluating Managed Network . prospectively evaluated . evaluating pirfenidone . Intervention Trial Evaluating . evaluating adecatumumab . evaluating tivozanib . evaluating aflibercept . evaluating CK # . Trial Evaluating . evaluating Nexavar . When evaluating Antigenics *

Related by context. All words. (Click for frequent words.) 81 assessing 79 evaluate 73 reviewing 70 analyzing 66 examining 64 evaluates 64 evaluated 62 assess 58 evaluation 56 reevaluating 56 exploring 56 determining 56 reexamining 56 examine 55 reassessing 54 researching 53 analyze 53 assesses 53 scrutinizing 53 Evaluating 52 discussing 52 formulating 51 comparing 51 appraising 50 studying 50 preclinical studies Vion 49 considering 48 optimizing 48 quantifying 48 determine 48 gauging 48 valuating 47 prioritizing 47 evalute 47 review 47 selecting 47 Yamana Pilar Au 47 consider 46 reevaluate 46 validating 46 sizing 46 stage Serrote Deposit 46 ascertaining 46 spotted owl demographics 46 Assess 45 Evaluate 45 reviewed 45 measuring 45 interviewing 45 continually evaluates 44 examined 44 identifying 44 revising 44 analyzed 44 reassess 44 relooking 43 maximizing 43 investigating 43 IFRS changeover 43 scrutinize 43 deciding 43 monitoring 43 pondering 43 calculating 43 reexamine 43 classifying 43 soliciting bids 42 Evaluates 42 Al Hamili echoed 42 updating 42 fabric filler protruding 42 pharmacodynamic markers 42 implementing 42 intellectual property Blecher 42 analyzes 42 inspecting 42 evaluations 42 finalizing 42 mulling 42 evaulate 42 depth Rubinger 41 results Martin Kotthaus 41 establishing 41 bioleach 41 inventorying 41 indentifying 41 altering Kirstie 41 verifying 41 monitor 41 categorizing 41 · Demonstrated 41 Roland Weichert 41 enhancing 41 carefully scrutinize 41 actively pursuing 41 affecting NovaMed 41 ENRICH trial 41 Understand companys 41 dissecting 41 devising 41 DELISTING REVIEW 41 developing 40 Assessing 40 evalution 40 factoring 40 Adolor urges 40 surveying 40 reconsidering 40 acquainting 40 determing 40 optimize 40 standardizing 40 familiarizing 40 evaulation 40 compare 40 underlying sulfide mineralization 40 assessed 40 genomic biomarkers 40 individualize therapy 40 Alternative Scenarios 40 looking 40 revaluating 40 adjusting 40 assesing 40 adopting IFRS 40 recalibrating 40 checking 40 evaluating Questcor 40 DEEP AF 40 Reviewing 40 calibrating 40 DataDrill 40 reevaluates 39 objectively evaluate 39 significantly undervalues Rio Tinto 39 deforolimus 39 ACCLAIM II 39 Accurately assessing 39 MedGuardian 39 Anticipation Advantage 39 sole determiner 39 reanalyzing 39 hypoxia selective 39 Magino mine 39 aligning 39 valuate 39 incorporating 39 modifying 39 biostatistical analysis 39 examing 39 improving 39 scoping 39 Digital Camera Satisfaction Study 39 solicits input 39 WikiWealth.com s 39 assigning 39 Invitel Holdings operates 39 familiarizing themselves 39 diagnosing 39 peripheral vascular diseases 39 focusing 39 refine 39 debating 39 evaluating Zhongpin 39 investigate 38 SCENARIOS Possible 38 Pfizer respectfully disagrees 38 ongoing Phase IIIb 38 treating 38 subjective determinations 38 hepatotoxic effects 38 Hematide ™ peginesatide 38 assessment 38 lorvotuzumab mertansine 38 explore 38 estimating 38 differentiating 38 assign probabilities 38 feasibility 38 compiling 38 Rumbeiha 38 adaptive reuses 38 careful consideration 38 consummating acquisitions 38 PadGadget Apps Tracker 38 revisiting 38 Develop 38 calculating SS NOI 38 testing 38 augmenting 38 pharmaceutically relevant 38 recalculating 38 reanalyze 38 salmonella contamination Meijer 38 Pharmacopeia urges 38 Phase IIb III 38 NASDAQ KMGB global 38 BLA filing 38 preparing 38 FAD variously defined 38 recommending 38 vigabatrin GABA aminotransferase inhibitor 38 CTLA4 Ig product 38 actively exploring 38 utilizing 38 pursuing 38 quantify 38 Determining 38 engineered nanoscale 38 noninvasively measuring 37 determines 37 Platinex focuses 37 workwith 37 reevaluated 37 weighing 37 immunotherapeutic approaches 37 LTAC certification 37 Outperform Perform Underperform 37 Hadyn Butler P.Geo 37 multivariate statistical 37 condensate stripping 37 Study PFS 37 Schering-Plough/Merck 37 evaluative 37 realizability 37 integrating 37 contemplating 37 coding debugging 37 triaging 37 pharmacodynamic endpoints 37 lupus renal disease 37 considers 37 interviewing witnesses 37 structuring 37 familiarizing himself 37 TWST What 37 stocks Outperform Mkt 37 realigning 37 designing 37 sifting 37 wrote Johann Pitout 37 maximize 37 Careful consideration 37 analysis 37 ascertain 37 Phase #/#a clinical 37 Provides textual analysis 37 Examine 37 rethinking 37 Regulus Alnylam 37 resultsof 37 losses UTEK dependence 37 calculate 37 Vaxfectin R 37 stratify 37 prognostic biomarker 37 Riken supplier 37 deCODE AF TM 37 PassMark Software conducted 37 BFPET 37 toimplement 37 analy sis 37 adequacies 37 SS NOI helps 37 Spokeswoman Amy Louviere 37 searching 37 Co KUFPEC 37 candidates Albania Bosnia 37 critiquing 37 chicken nuggets KFC 37 novel oral anticoagulant 37 comparing apples 37 formulate 37 seeking quali MORE 36 PDX pralatrexate 36 determinations 36 enables GeneThera 36 deliberating 36 examines 36 explored 36 Management compensates 36 FFO Measures 36 NOTES Hillen 36 Predilecta claim blocks 36 figuring 36 create simpler nimbler 36 due diligence 36 materially misstate 36 fine tuning 36 overinterpreting 36 #.Analysts say 36 experimenting 36 reassesses 36 EMPOWER TM 36 anti JCV antibody 36 markets spectrophotometry 36 StockMarks framework 36 vi ineffectiveness 36 Phase III LibiGel 36 forming strategic alliances 36 ICP MS AAS 36 Canvaxin TM 36 Trofex 36 objectively 36 whitepaper outlines 36 assigning probabilities 36 Divigel R 36 visualizing 36 Fully conversant 36 suitablef 36 Storie molybdenum 36 sapacitabine CYC# 36 removing barred owls 36 Bacterin proprietary 36 Generally Accepted Accounting Principle 36 metallurgical recoveries refining 36 applying 36 benchmarking 36 feasability 36 maximize stockholder 36 scrutinizes 36 examining VBLOC Therapy 36 conducting 36 defining 36 metabolomic profiling 36 IntroductionThe 36 apprising 36 tubulin inhibitor 36 neratinib 36 xxxi adverse tax 36 · Coordinate 36 characterizing 36 imprudently invested 36 eyeballing 36 Prosaptide 36 aggressively pursuing 36 consideration 36 Secondary endpoints include 36 carbohydrate polymers 36 Thalomid R 36 Here'sa breakdown 36 enhances comparability 36 provide TransCanada securityholders 36 advise 36 tables summarize 36 pilot readback error 36 Beardmore Camp 36 reallocating resources 36 segmenting 36 evaluative criteria 36 tolerability pharmacokinetics 36 feasiblity study 36 Cyberlux Corporation SEC 36 Phase #b/#a trial 36 PRECISE Trial 36 valuing illiquid 36 appraise 36 RH1 targeted chemotherapeutic agent 36 METAspectrum evaluation provides 36 CardioPET 36 studied 36 HIV RDEA# 36 proprietary Isolagen Process 36 discussed 36 MGN# 36 minimizing 35 C#/C#ISR 35 managing 35 Overweight Neutral Underweight 35 RBSSC 35 Phase IIb clinical trials 35 prognostic indicators 35 Transformational Outsourcing working 35 assisting 35 integrate restructurings consolidations 35 capacitance voltage 35 pharmacodynamic PD 35 familiarizing yourself 35 MSCRAMM 35 Inc. NASDAQ TRMP 35 using TCA grading 35 trialling 35 OptiCon R4 35 withrespect 35 maximizing stockholder 35 tabulating 35 empiric therapy 35 Bayesian statistical 35 MYTHOS trial 35 deploying 35 adapting 35 PD2i ® algorithm 35 Puricase PEG uricase 35 whitepaper explores 35 consolidating 35 Oral NKTR 35 detailed SCPT strengths 35 ImmuneY2 35 interpreting 35 dioxin reassessment 35 hypoxia activated prodrug 35 Linjeta TM 35 MGCD# clinical trials 35 Bucko Lake Project 35 geological geophysical geochemical 35 ColorectAlert TM 35 BioSante LibiGel Phase III 35 improperly backdated 35 confirmatory pivotal 35 Spokeswoman Emily Langlie 35 RFP RFI 35 Secondary efficacy endpoints 35 OSI Eyetech 35 indicates prosecutable violation 35 spokesperson Seth Palansky 35 Dynegy cautions 35 basing 35 assembling 35 therapeutic radiopharmaceuticals 35 carcinogenicity studies 35 RSEI 35 disable virulence 35 Feeling ilikemusic 35 Bogaert studied 35 iv unanticipated 35 periodically reassessed 35 redefining 35 tolerability profiles 35 coalitions Dominy 35 Adequate yearly 35 Quantify 35 SmartChip TM product 35 romazarit 35 chemoprevention trials 35 Val MARC 35 WCED hosts 35 predictive biomarker 35 Vertos II 35 acquisitions divestitures strategic alliances 35 observing 35 collating 35 Staying abreast 35 Seattle Angina Questionnaire 35 portfolio UTEK dependence 35 naronapride 35 re evaulate 35 multivariate regression 35 digesting 35 CLIRS trial 35 Reassess 35 solution Cybercity initially 35 auditee 35 GLPG# 35 too geologically speculative 35 Mtsare Khevi Field 35 individualizing 35 beconsidered 35 FYI Stifel Nicolaus 35 Determine 35 spokeswoman Cathy Milbourn 35 much BlueBeat owed 35 demonstrated clinically meaningful 35 investigated 35 neuropathy sparing 35 verifies 35 neural crest stem cell 35 postoperative ileus POI 35 Acetavance TM intravenous acetaminophen 35 Dr. Boadie Dunlop 35 spokesman Don Vecchiarello 35 acquiring 35 RFI RFP 35 occurs Varmus 35 APPRAISE 35 BACcel 35 Psychometric tests 35 KPIs metrics 35 principal benchmarking sizing 35 reserving judgment 35 basal insulin analogue 35 Allovectin 7 ® 35 eTag assays 35 genomic biomarker 35 nonprescription NSAIDs 35 Restaurant Swedish Foodmarket 35 randomly assigning 35 Evaluation 35 correlating 35 Canon imageRUNNER MFPs 35 Assesses 35 identify 35 EcaFlo 35 Ken Godskind chief 35 indications contraindications 35 Shigamabs 35 Ongoing metallurgical 35 noncognitive 35 summarizing 35 reassessed 35 Examining 35 lung cancer chemoprevention 35 allocating 35 NOI SS NOI 35 power petrochemical metallurgy 35 Monza aero 35 develop 34 todetermine 34 contingent guaranties 34 Rating Linkage 34 Vaxfectin TM 34 ARID tool 34 MB# MB# 34 Canariaco Norte copper 34 orienting 34 physicians individualize 34 feasibilty study 34 during Neitling postseason 34 likelihoods 34 addressing 34 bioFILM PA TM 34 integrally involved 34 revealed un Earthlike 34 ORE# 34 subjective 34 value Amiworld continuously 34 Tables reconciling 34 Concurrent Everstream line 34 attorney William Settina 34 clarifying 34 researched 34 nonhormonal treatment 34 RFP RFQ 34 Analyzing 34 Six Sigma Lean 34 pafuramidine 34 Usable Light 34 MOU contemplates 34 upgrading 34 SIMPADICO 34 targeting abnormally proliferating 34 Randy Belote 34 Mantel Haenszel 34 DITPA 34 adjuvant GIST 34 evaluators 34 Shopper Events positions 34 Buen Futuro 34 · Oversee 34 situ extraction 34 pain palliation 34 PowerRating DELISTING REVIEW 34 neuroactive 34 FEDMFC 34 Check 34 define 34 Panzem R NCD 34 urate lowering 34 advising 34 reappraising 34 SUCCEED trial 34 regarding GreenChek 34 DCPP 34 torsemide ER 34 iron ore Arapiraca Project 34 LibiGel NDA 34 NAEY 34 recombinant clotting 34 KRAS mutation status 34 quantitatively assess 34 PrevOnco ™ 34 tended lawns mowed 34 SWOT strengths 34 lymphatic mapping 34 xi unanticipated 34 Uhhhhh Bosh 34 Lamaque property 34 Analyze 34 TransVax tm 34 Smithfield BioEnergy 34 discuss 34 Carolinas PEC 34 Volkow explains 34 choosing 34 SEDAR.com 34 WME ranking 34 possible responses Goshko 34 scrutinized 34 SPEC MPI# 34 accommodate procrastinators 34 developing ViaCyte SM 34 noninvasive diagnostic 34 ultimate recoverability 34 cariprazine 34 placebo controlled multicenter 34 PharmFilm 34 Mud flaps 34 EORTC QLQ C# 34 Protalex 34 Prefeasibility Study 34 mischaracterizing 34 externally Jaffe 34 perusing 34 EcaFlo ® equipment 34 EMPOWER ™ 34 biowarfare detection 34 website www.bancroftfund.com 34 APEX AMI 34 affecting Pennichuck Corporation 34 CRMD# 34 Partially mitigating 34 non topical formulations 34 molecular chaperone regulation 34 UA NSTEMI 34 OpenNotes 34 expanding 34 dispositions financings 34 redesigning 34 feasibility studies 34 spokeswoman Susan Garontakos 34 Avastin adjuvant 34 feasibilities 34 GERD migraine headaches 34 chemically modified tetracyclines 34 endothelin antagonist 34 WOTs 34 BLOOM DM 34 small molecule chemotherapeutic 34 meta cognitive 34 brine inflows 34 presenting 34 Chuch Phoeun 34 atrial arrhythmias 34 spokeswoman Marna Daley 34 calibrate 34 chemokine receptor CCR1 34 sporicidal product 34 hydrogeologic 34 GEM OS2 34 WiROI 34 Greenhill Caliburn 34 reaccredit 34 NCQA accreditation 34 please visit http:/www.weingarten.com 34 SF CDO approach 34 preclinical pharmacology 34 thoughtful deliberative 34 regarding AngelCiti 34 ritonavir boosted danoprevir 34 Augment Injectable 34 certifying blowout preventers 34 Carticept 34 considered 34 metocean 34 PROTECT II 34 REVIVE Diabetes 34 Analyzes 34 dermaceutical 34 residual confounding 34 teplizumab 34 #,# hectare Invicta 34 rPA vaccine candidate 34 ADME properties 34 obsessively profiling 34 CMV vaccine 34 distal embolic protection 34 Primary endpoints 34 Equinix excludes 34 Alequel ™ 34 Still Wootan 34 pharmacological therapy 34 honors CableOrganizer.com 34 validated 34 mineability 34 paints rosier picture 34 Visit www.transre.com 34 CompactSafe TM 34 PK PD modeling 34 RELIANT trial 34 PITX2 34 HCV antiviral 34 cardiac ultrasounds 34 remediating 34 Anturol TM 34 TABLE #.OS -#/# parent 34 proprietary MSCRAMM protein 34 Perform Underperform 34 figitumumab CP 34 By DAVID SCHEPP 34 Nemegosenda Project 34 VeraTag assays 34 Identify 34 commercialize lorcaserin 34 PCORI 34 interrogating 34 ZYBRESTAT fosbretabulin 34 Studies #CL# #CL# #CL# 34 assign 34 regarding 34 andmanagement 34 ISO IEC #:# accredited 34 scouring 34 Concur excludes 34 Bridgestone Potenza tire 34 Phase IIa proof 34 rationalizing 34 keeping tabs 34 metallurgical flowsheet 34 opioid bowel dysfunction 33 validate 33 pyrometallurgical 33 endangered bowhead whales 33 ceoforum.com.au What 33 ACAPODENE TM 33 initiate Phase 1b 33 Ombudstvedt 33 MiCK assay 33 onset AF 33 Transocean unwavering commitment 33 adversely affect Hologic 33 oil Momgeri 33 co receptor tropism 33 ICD therapy 33 leveraging 33 FFR measurements 33 VerifyNow P#Y# 33 Hormone receptor 33 Flow cytometry 33 MediGene focuses 33 pros cons 33 adversely effecting 33 Allin leverages 33 stratifying patients 33 unattractive Cimbala 33 Marc Altieri 33 educating 33 Computer Assisted Retinal 33 recombinant plasma 33 Toromocho Project 33 reducing 33 inspecting malfunctioning rotary 33 spokeswoman Trish Nicasio 33 pharmacodynamic parameters 33 LandStar Inc. s 33 Helena Ostman spokeswoman 33 deCODE Genetics Illumina Navigenics 33 incyclinide 33 treating psychiatric disorders 33 Trofex ™ 33 Magneceutical ® Therapy 33 focusedon 33 Borrower Benefits 33 pharmacokinetic pharmacodynamic 33 Jesse Blout San Francisco 33 spokeswoman Heidi Valetkevitch 33 divesting 33 HDL Selective Delipidation 33 Formative assessment 33 futher actions 33 ratio ICER 33 NASDAQ FLML 33 XP# XP# 33 next generation URAT1 33 Levulan ® PDT 33 QTinno ™ 33 Magino Mine project 33 JM Dutton adds 33 thereby blunting 33 BMC ProactiveNet Performance 33 scalability necessitates 33 Pantanillo 33 include MedGuardian patient 33 NADiA 33 Cisco VQE 33 prepping 33 MDEP 33 constructability 33 Urocortin 2 33 taribavirin 33 fibrotic disorders 33 revaluate 33 initiate Phase IIb 33 Walt Rakowich 33 MedStrong 33 mitigating 33 RIGScan CR 33 arenot limited 33 Assessment Scoping Study 33 inquiring 33 Guthreau 33 examines Chinas 33 TobacAlert TM tests 33 introducing 33 vitro dissolution 33 investigational humanized monoclonal antibody 33 AVI RNA based 33 Rescula 33 UTEK dependence 33 Dr. Coppari 33 Chepica 33 Phase #b/#a 33 XL# anticancer compounds 33 EBITDA EBITDAM EBITDAR 33 HepeX B TM 33 STEDESA 33 subthreshold depression 33 outlining 33 includedin 33 FavId 33 MT#A BTS Master 33 permitting timelines 33 potent suppressor 33 Philippe Boursereau spokesman 33 concentrating 33 diagnostic prognostic 33 situ leach 33 topical agent Xantryl 33 franchise reacquisitions 33 Xphase principals 33 SolutionsPath 33 innovative AHP pigment 33 NWND 33 BWise enables 33 depicts Gartner 33 remediating contaminated 33 Medworxx UMS 33 bioengineered tissue 33 characterization unmet 33 discusses 33 caustic fusion diamond 33 waterflooding 33 acquainting himself 33 pharmacologic stress 33 nextgen sequencing 33 Ellis Brachman spokesman 33 reduced cardiotoxicity 33 emphasizing 33 Pre RELAX AHF 33 contended Bacanovic doctored 33 dashboards scorecards 33 Polyethylene terephthalate 33 Galeno copper gold 33 OREXIGEN 33 ulimorelin 33 stratifying 33 diagnose clinically 33 Visian Toric ICL 33 Q#IR 33 regarding Flotek Industries 33 facilitates comparisons 33 Actively participates 33 CMMI maturity 33 reexamined 33 APD# 33 oceanwide tsunami 33 visually inspecting 33 tipped Canion 33 Lac Rocher 33 Army sharpshooters crouched 33 malignant mesothelioma Alfacell 33 removing XCP 33 unanimous Jagland 33 reteaching 33 ONGOING Kruckeberg Botanic Garden 33 Briggs discusses NCCAM 33 benchmarked 33 ProLogis Kingspark 33 extrapolating 33 Pricing varies depending 33 biophotonic imaging 33 manufacture RISPERDAL CONSTA 33 virtual alphanumeric keypad 33 CLX Investments 33 Acrylamide forms 33 OMS# 33 Nirvanix SDN versus 33 Responsys leverages proven 33 empirically validated 33 mull 33 excretion ADME 33 LS Grande 33 improve 33 revamping 33 viabilities 33 animal xenograft models 33 spokeswoman Susan Ziadeh 33 BancTec offerings include 33 toenail nicotine 33 MoxDuo TM IR 33 LEVADEX ™ 33 Dataflow Manager 33 thetreatment 33 Oxide Project 33 cardiometabolic 33 elaborating 33 CTCAE 33 QTinno 33 PRIMO CABG 33 amortization EBITDA adjusted EBITDA 33 mutually exclusive strands 33 prioritize 33 Gahcho Kué 33 workplans 33 minor leaguer Joba Chamberlain 33 Dr. Aravind Arepally 33 locating 33 Coremetrics Benchmark 33 signed nondisclosure agreements 33 El Colmillo gold 33 Linjeta ™ 33 engineering BPR 33 subcutaneous bremelanotide 33 cortical stimulation 33 Homeownership bestows 33 EarthLink connects 33 Cimzia TM 33 deferring 33 pharmacogenomic diagnostic 33 pharmacodynamic effects 33 corneal refractive surgery 33 Genz # 33 Superintendent Roseann Nyiri 33 generation rotary VAD 33 REGEN trial 33 vaccine GMK 33 unblinding 33 Reevaluate 33 double helix molecular 33 Masami Nishimura spokesman 33 Phase IIIb study 33 availableto 33 triglyceride lowering 33 muscarinic receptor agonists 33 municipal recalibration 33 www.sanbolic.com 33 midstage clinical trials 33 Systematic reviews draw 33 familiarized 33 initiate Phase IIa 33 sirtuin modulators 33 empirically derived 33 ovarian cancer biomarker 33 ChicagoSports.com coverage 33 Make bootable backups 33 sorting 33 NP2 Enkephalin 33 Everstream measure 33 Phase III metastatic melanoma 33 exploratory endpoints 33 Marianne Rencher lawyer 33 VQM 33 Gloria Vanderham 33 subtitue prizing 33 enzyme immunoassay EIA 33 transcatheter valve technologies 33 includes TOLAMBA TM 33 finding 33 oxypurinol 33 MEND CABG II 33 PowerPC #GT 33 sNDAs 33 Calmare pain 33 laboratorians 33 SemGroup LP SemGroup 33 Liver biopsy 33 Primary Porphyry 33 overinterpreting upcoming data 33 reliable predictor 33 monoclonal antibody biologic 33 playmaking toughness 33 Quantext Portfolio Planner QPP 33 Multivariate Index 33 impartiality openness 33 commercialization stakeholder 33 metrics 33 Neuradiab 33 PTPA winners 33 existing wellbores 33 blackbird baiting 33 corrosivity 33 cryosurgical treatment 33 revising downward 33 airstrikes judiciously 33 Technical Symbology Committee 33 Tarvacin Anti Cancer 33 believes EBDDT 33 Carotid endarterectomy 33 piece mealing 33 inks pigments 33 pharmacodynamics PD 33 Confirmatory tests 33 Yenichek 33 DGGS 33 APPROVe trial 33 Sac Pocohontas 33 showing Darvon interferes 33 Tissue Repair Cell 33 Boomerang massive sulphide 33 antiplatelet therapies 33 Bonasika Project

Back to home page